Analysis of different ways of drainage for obstructive jaundice caused by hilar cholangiocarcinoma

Chuan Xu1, Peng-Hua Lv, Xin-En Huang

  • 1Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University, Yangzhou, China

Insights

Percutaneous transhepatic biliary stenting (PTBS) offers better prognosis than percutaneous transhepatic catheter drainage (PTCD) for obstructive jaundice in hilar cholangiocarcinoma patients. PTBS significantly prolonged survival time compared to PTCD.

Area of Science:

  • Hepatobiliary surgery
  • Interventional radiology
  • Gastroenterology

Background:

  • Hilar cholangiocarcinoma causes obstructive jaundice, requiring effective biliary drainage.
  • Percutaneous transhepatic biliary interventions are crucial for managing such cases.

Purpose of the Study:

  • To compare the prognostic outcomes of percutaneous transhepatic catheter drainage (PTCD) and percutaneous transhepatic biliary stenting (PTBS) in patients with obstructive jaundice due to hilar cholangiocarcinoma.

Main Methods:

  • A retrospective analysis of 89 patients undergoing PTCD or PTBS between January 2006 and March 2012.
  • Drainage method selection was based on guidewire passage, infection status, and pre-procedure cholangiography.
  • Outcomes evaluated included liver function markers (ALT), recurrence of obstruction, and patient survival.

Main Results:

  • Both PTCD and PTBS demonstrated significant improvements in bilirubin and ALT levels.
  • The average survival time was notably longer for PTBS (243 days) compared to PTCD (161 days).

Conclusions:

  • Both PTCD and PTBS are effective in improving liver function for obstructive jaundice caused by hilar cholangiocarcinoma.
  • PTBS is superior to PTCD in terms of prolonging patient survival.
Abstract